We are aware of current issues with the ONS login. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
cancel
Combination Immunotherapy May Further Increase Melanoma Survival Length
Elisa Becze, BA, ELS, Editor
Voice
Description
Using two agents that target two different receptors more than doubles length of survival for advanced melanoma than a single agent alone, researchers reported at the 2021 American Society of Clinical Oncology annual meeting.